Source: European Parliament
pursuant to Rule 149 of the Rules of Procedure
Tomasz Froelich, Gerolf Annemans, Anja Arndt, Paolo Borchia, Zsuzsanna Borvendég, Irmhild Boßdorf, Stine Bosse, Markus Buchheit, Virginie Joron, Alexander Jungbluth, Jacek Ozdoba, Friedrich Pürner, Katarína Roth Neveďalová, Alexander Sell, Isabella Tovaglieri
B10‑0309/2025
Motion for a European Parliament resolution on underinvestment in endometriosis research
The European Parliament,
– having regard to Rule 149 of its Rules of Procedure,
A. whereas endometriosis is associated with a range of often debilitating symptoms;
B. whereas endometriosis carries the risk of infertility and therefore has a negative impact on demography;
C. whereas endometriosis affects around 14 million women in Europe;
D. whereas endometriosis has a substantial economic impact, with direct healthcare costs, indirect costs related to lost productivity at work, and the financial burden of infertility treatments;
E. whereas the cost of endometriosis-related sick leave in the EU is estimated at EUR 30 billion annually;
F. whereas at EU level only 27 out of a total of 145 983 projects funded (0.02 %) were related to endometriosis[1];
1. Is of the opinion that funding dedicated to endometriosis at EU level is completely inadequate and not in proportion to the considerable health and social burden attributable to this disorder;
2. Calls on the Commission to give a much higher priority to endometriosis in health funding in order to promote women’s health and fertility;
3. Encourages the Member States to raise awareness of endometriosis and to invest in innovative research initiatives.
- [1] Vigano, P. et al., ‘European Union underinvestment in endometriosis research’, Journal of Endometriosis and Uterine Disorders, Vol. 5, March 2024.